213 related articles for article (PubMed ID: 15116321)
1. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity analysis shows monoclonal evolution with frequent genetic progression and divergence in esophageal carcinosarcoma.
Matsumoto T; Fujii H; Arakawa A; Yamasaki S; Sonoue H; Hattori K; Kajiyama Y; Hirose S; Tsurumaru M
Hum Pathol; 2004 Mar; 35(3):322-7. PubMed ID: 15017588
[TBL] [Abstract][Full Text] [Related]
3. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity.
Fujii H; Yoshida M; Gong ZX; Matsumoto T; Hamano Y; Fukunaga M; Hruban RH; Gabrielson E; Shirai T
Cancer Res; 2000 Jan; 60(1):114-20. PubMed ID: 10646862
[TBL] [Abstract][Full Text] [Related]
4. Genetic classification of combined hepatocellular-cholangiocarcinoma.
Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
6. Extensive and divergent chromosomal losses in squamous and spindle-cell components of esophageal sarcomatoid carcinoma.
Kwon MS; Hong SJ; Cho HA; Ahn GH; Lee SS; Lee KY; Rhyu MG
Virchows Arch; 2003 Nov; 443(5):635-42. PubMed ID: 12928897
[TBL] [Abstract][Full Text] [Related]
7. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
8. Losses of heterozygosity on chromosomes 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis.
Hidaka E; Yanagisawa A; Sakai Y; Seki M; Kitagawa T; Setoguchi T; Kato Y
J Cancer Res Clin Oncol; 1999; 125(8-9):439-43. PubMed ID: 10480335
[TBL] [Abstract][Full Text] [Related]
9. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
11. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.
Fujii H; Szumel R; Marsh C; Zhou W; Gabrielson E
Cancer Res; 1996 Nov; 56(22):5260-5. PubMed ID: 8912866
[TBL] [Abstract][Full Text] [Related]
12. Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses.
Nobukawa B; Fujii H; Hirai S; Kumasaka T; Shimizu H; Matsumoto T; Suda K; Futagawa S
Am J Surg Pathol; 1999 Oct; 23(10):1280-7. PubMed ID: 10524531
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
[TBL] [Abstract][Full Text] [Related]
14. Undifferentiated spindle cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and flow cytometric study of 11 cases.
Nishihara K; Tsuneyoshi M
Hum Pathol; 1993 Dec; 24(12):1298-305. PubMed ID: 8276377
[TBL] [Abstract][Full Text] [Related]
15. Genetic progression and divergence in pancreatic carcinoma.
Yamano M; Fujii H; Takagaki T; Kadowaki N; Watanabe H; Shirai T
Am J Pathol; 2000 Jun; 156(6):2123-33. PubMed ID: 10854233
[TBL] [Abstract][Full Text] [Related]
16. Genetic evolution of alpha fetoprotein producing gastric cancer.
Fujii H; Ichikawa K; Takagaki T; Nakanishi Y; Ikegami M; Hirose S; Shimoda T
J Clin Pathol; 2003 Dec; 56(12):942-9. PubMed ID: 14645355
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in ampulla of Vater neoplasms during adenoma-carcinoma sequence.
Park S; Kim SW; Kim SH; Lee BL; Kim WH
Anticancer Res; 2003; 23(3C):2955-9. PubMed ID: 12926143
[TBL] [Abstract][Full Text] [Related]
18. Genetic pattern of prostate cancer progression.
Saric T; Brkanac Z; Troyer DA; Padalecki SS; Sarosdy M; Williams K; Abadesco L; Leach RJ; O'Connell P
Int J Cancer; 1999 Apr; 81(2):219-24. PubMed ID: 10188722
[TBL] [Abstract][Full Text] [Related]
19. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas.
Fujii H; Inagaki M; Kasai S; Miyokawa N; Tokusashi Y; Gabrielson E; Hruban RH
Am J Pathol; 1997 Nov; 151(5):1447-54. PubMed ID: 9358771
[TBL] [Abstract][Full Text] [Related]
20. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.
Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P
Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
